Fusion Pharmaceuticals Announces Research Collaboration with 48Hour Discovery to Develop Peptide-Based Radiopharmaceuticals

January 11, 2022 | | Press Releases |

Original Post from: https://ir.fusionpharma.com/2022-01-11-Fusion-Pharmaceuticals-Announces-Research-Collaboration-with-48Hour-Discovery-to-Develop-Peptide-Based-Radiopharmaceuticals HAMILTON, Ontario and BOSTON, Jan. 11, 2022 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced the company has entered into a strategic...

Read More

48Hour Discovery and RayzeBio Announce Strategic Research Collaboration

July 12, 2021 | | Press Releases |

Link to Business Wire article: https://www.businesswire.com/news/home/20210712005120/en/48Hour-Discovery-and-RayzeBio-Announce-Strategic-Research-Collaboration-to-Discover-Develop-Novel-Peptide-Based-Radiopharmaceuticals Edmonton, AB Canada, & San Diego, CA, USA 48Hour Discovery Inc and RayzeBio today announced the companies have entered a strategic research collaboration to discover and develop novel peptide-based radiopharmaceuticals for the treatment...

Read More

48Hour Discovery’s ‘molecule libraries’ help speed the search for new drugs

June 4, 2021 | | Press Releases |

Original post at https://www.ualberta.ca/folio/2021/06/48hour-discoverys-molecule-libraries-help-speed-the-search-for-new-drugs.html U of A spinoff company works with some of the world’s largest pharmaceutical companies to streamline an expensive and time-consuming process. June 04, 2021 By Michael Brown U of A chemistry professor and 48Hour Discovery...

Read More

Leveraging AI for Drug Discovery

May 14, 2021 | | Press Releases |

Edmonton, AB, Canada, May 11, 2021 Hosted by Edmonton Global: the panelists included Jessica Cao, our VP of Data Science and Information Technology, Fanny Sie, head of Artificial Intelligence and Digital Health at Roche, Dr. John Mackey, Professor of...

Read More

48Hour Discovery and Merck initiate drug discovery project

March 15, 2021 | | Press Releases |

— Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform EDMONTON, AB, CANADA, March 15, 2021 https://www.einpresswire.com/article/536733307/48hour-discovery-and-merck-initiate-drug-discovery-project — 48Hour Discovery(48HD) and CQDM are proud to announce that the company...

Read More

48Hour Discovery and Quantum Intelligence Corp Join Forces to Form Quantum Intelligence Discovery (QID) – An AI-Powered Drug Discovery Venture

January 13, 2021 | | Press Releases |

View the original post at businesswire.com EDMONTON, Alberta–(BUSINESS WIRE)–48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint venture called Quantum Intelligence Discovery. This joint venture between the two start-ups is expected to establish...

Read More

Nova Cell Technology signs a joint research and technology transfer option contract with Canada’s 48Hour Discovery Inc.

January 4, 2021 | | Press Releases |

(From the PharmNews website of the Korean Business Journal. 출처 : 팜뉴스http://www.pharmnews.com) View the original post at pharmnews.com Novacell Technology Co., Ltd. (Novacell), a Korean biotechnology company that develops peptide immunotherapy, as an affiliate of Donggu Biopharmaceutical, a pharmaceutical/bio-specialized company, and  48 Hour...

Read More